Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke

L Nie, D Yao, S Chen, J Wang, C Pan, D Wu… - Cell Death …, 2023 - nature.com
Due to the limited capacity of the adult mammalian brain to self-repair and regenerate,
neurological diseases, especially neurodegenerative disorders and stroke, characterized by …

Drug screening for human genetic diseases using iPSC models

MS Elitt, L Barbar, PJ Tesar - Human molecular genetics, 2018 - academic.oup.com
Induced pluripotent stem cells (iPSCs) enable the generation of previously unattainable,
scalable quantities of disease-relevant tissues from patients suffering from essentially any …

Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease

Z Wu, M Parry, XY Hou, MH Liu, H Wang, R Cain… - Nature …, 2020 - nature.com
Huntington's disease (HD) is caused by Huntingtin (Htt) gene mutation resulting in the loss
of striatal GABAergic neurons and motor functional deficits. We report here an in vivo cell …

CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington's disease mouse model

FK Ekman, DS Ojala, MM Adil, PA Lopez… - … Therapy-Nucleic Acids, 2019 - cell.com
Huntington's disease (HD) is a currently incurable and, ultimately, fatal neurodegenerative
disorder caused by a CAG trinucleotide repeat expansion within exon 1 of the huntingtin …

Electrophysiology, unplugged: imaging membrane potential with fluorescent indicators

P Liu, EW Miller - Accounts of chemical research, 2019 - ACS Publications
Conspectus Membrane potential is a fundamental biophysical property maintained by every
cell on earth. In specialized cells like neurons, rapid changes in membrane potential drive …

Cell encapsulation and 3D bioprinting for therapeutic cell transplantation

A Samadi, A Moammeri, M Pourmadadi… - ACS Biomaterials …, 2023 - ACS Publications
The promise of cell therapy has been augmented by introducing biomaterials, where
intricate scaffold shapes are fabricated to accommodate the cells within. In this review, we …

Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease

YY Wu, FL Chiu, CS Yeh… - Royal Society Open …, 2019 - royalsocietypublishing.org
Adult-onset neurodegenerative diseases are among the most difficult human health
conditions to model for drug development. Most genetic or toxin-induced cell and animal …

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward

AC Bachoud-Lévi, R Massart, A Rosser - Stem Cells, 2021 - academic.oup.com
Huntington's disease (HD) is a rare inherited neurodegenerative disease that manifests
mostly in adulthood with progressive cognitive, behavioral, and motor dysfunction. Neuronal …

Huntington's disease: complex pathogenesis and therapeutic strategies

H Tong, T Yang, S Xu, X Li, L Liu, G Zhou… - International Journal of …, 2024 - mdpi.com
Huntington's disease (HD) arises from the abnormal expansion of CAG repeats in the
huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) …

On the right track to treat movement disorders: promising therapeutic approaches for Parkinson's and Huntington's disease

P Troncoso-Escudero, D Sepulveda… - Frontiers in aging …, 2020 - frontiersin.org
Movement disorders are neurological conditions in which patients manifest a diverse range
of movement impairments. Distinct structures within the basal ganglia of the brain, an area …